VALIRX PLC Logo

VALIRX PLC

Life science company developing therapeutics for oncology and women's health.

VAL | IL

Overview

Corporate Details

ISIN(s):
GB00BLH13C52
LEI:
213800VQKB9SJCQDET40
Country:
United Kingdom
Address:
STONEBRIDGE HOUSE, CM22 7BD HATFIELD HEATH

Description

ValiRx PLC is a life science company that accelerates the development of therapeutics and diagnostics, with a primary focus on oncology and women's health. The company's business model centers on identifying and progressing promising early-stage scientific discoveries through pre-clinical and clinical development. ValiRx provides scientific, financial, and commercial expertise to translate novel research into clinically validated treatments, aiming to improve patient outcomes in its target therapeutic areas.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2013-12-05 08:00
New Australian Patent Grant
English 22.6 KB
2013-11-28 08:00
Update re Positive VAL201 & Biomarker Unit Studies
English 22.2 KB
2013-11-15 08:00
Placing to raise £1m
English 12.9 KB
2013-11-01 08:00
Change of Broker
English 17.0 KB
2013-10-24 18:25
Re: VAL201 - Update
English 19.9 KB
2013-10-08 09:00
Directorate Changes
English 21.0 KB
2013-10-03 09:00
Re: VAL201 - Filing of Phase IB Clinical Trial
English 21.0 KB
2013-09-05 09:00
Half Yearly Report
English 205.7 KB
2013-08-15 09:00
Consortium incl. ValiRx Awarded Eurostars Grant
English 19.2 KB
2013-07-31 09:00
Update
English 20.6 KB
2013-06-13 09:00
Re: VAL201 Update
English 21.6 KB
2013-06-06 12:00
ValiRx admitted as founder member of the SSE
English 25.8 KB
2013-04-25 09:00
New Patent Granted
English 19.2 KB
2013-04-22 13:52
Result of AGM
English 10.3 KB
2013-03-28 08:01
Final Results
English 163.5 KB

Automate Your Workflow. Get a real-time feed of all VALIRX PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for VALIRX PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for VALIRX PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.